Log in to save to my catalogue

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survi...

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A635608767

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

About this item

Full title

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Publisher

Nature Publishing Group

Journal title

Cancer Gene Therapy, 2020, Vol.27 (9), p.669

Language

English

Formats

Publication information

Publisher

Nature Publishing Group

More information

Alternative Titles

Full title

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A635608767

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A635608767

Other Identifiers

ISSN

0929-1903

DOI

10.1038/s41417-019-0140-8

How to access this item